1K. Haasio,L. Sopanen,L. Vaalavirta,I.-B. Lindén,E. H. Heinonen. Comparative toxicological study on the hepatic safety of entacapone and tolcapone in the rat[J] 2001,Journal of Neural Transmission(1):79~91
6Zhang ZX, Roman GC, Hong Z, et al. Parkinson's disease in China:prevalence in Beijing, Xi'an and Shanghai [ J ]. Lancet, 2005,365 ( 9459 ) : 595 - 597.
8Hadj TA, Gregoire L, Bangassoro E, et al. Sustained cabergoline treatment reveres levodopa-induced dyskinesias in parkinsonian monkeys [ J ]. Clin Neuropharmaco1,2000,23 (4) : 195 - 202.
9Weiner WJ, Factor SA, Jankovic J, et al. The long-term safety and efficacy of pramipexole in advanced Parkinson' s disease [ J ]. Parkinsonism Retat Disord,2001,7(2) :115 - 120.
10Calne D,Schulzer M, Mak E,et al. Treatment for the progression of Parkinson's disease [ J ]. Lancet Neurol, 2005,4 (4) :206.